Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Accumulated Expenses (2018 - 2023)

Avai Bio's Accumulated Expenses history spans 5 years, with the latest figure at $410000.0 for Q3 2023.

  • For Q3 2023, Accumulated Expenses rose 157.05% year-over-year to $410000.0; the TTM value through Sep 2023 reached $410000.0, up 157.05%, while the annual FY2023 figure was $192600.0, N/A changed from the prior year.
  • Accumulated Expenses for Q3 2023 was $410000.0 at Avai Bio, down from $458600.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $458600.0 in Q2 2023 and bottomed at $1143.0 in Q4 2020.
  • The 4-year median for Accumulated Expenses is $176050.0 (2022), against an average of $165946.8.
  • The largest annual shift saw Accumulated Expenses skyrocketed 1105.77% in 2019 before it plummeted 99.48% in 2020.
  • A 4-year view of Accumulated Expenses shows it stood at $219795.0 in 2019, then tumbled by 99.48% to $1143.0 in 2020, then surged by 782.94% to $10092.0 in 2022, then surged by 3962.62% to $410000.0 in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Accumulated Expenses are $410000.0 (Q3 2023), $458600.0 (Q2 2023), and $192600.0 (Q1 2023).